Professor Ricardo Allegri: “Worldwide, there’s a new case of dementia every four seconds”
Professor Ricardo Allegri, a researcher from the CONICET, Argentina's Research Council, will take part in the World Dementia Council’s WDC 11 meeting in London on 20 and 21 July.
The World Dementia Council (WDC) fully endorses the statement made by the Council’s Country Associate Members, welcoming and supporting the World Health Assembly’s (WHA) adoption of the World Health Organization’s (WHO) Global Action Plan on the Public Health Response to Dementia.
The World Federation of Science Journalists’ (WFSJ) new website on dementia, http://www.wfsj.org/dementia/, which WDC has contributed to and is an active partner in, went live on the 1st June 2017.
The WFSJ dementia website is designed to be a toolkit for journalists in low or middle income countries (LMICs), providing them with the information they need to gather and report dementia related news and information accurately and sensitively.
WDC Chair, Yves Joanette and WDC Member and Trustee, George Vradenburg were both active participants in this year’s highly successful Dementia Forum X, in Stockholm, Sweden on 18th May 2017. Yves Joanette took part in a group discussion and Q&A session called Big Picture Dialogue and George Vradenburg was one of the speakers in a moderator led series of Inspirational Conversations.
The World Dementia Council (WDC) congratulates the trio of Presidencies of the Council of the EU 2016-17 on their Joint Statement on Dementia, issued on 15th May 2017.
To read the Joint Statement on Dementia, please click on the below link:
George Vradenburg convenes the Global CEO Initiative on Alzheimer’s (CEOi), a patient-centered industry coalition working with government, researchers and patients to develop and deliver innovative medicines to those touched by dementia and improve their quality of care. He also chairs the Global Alzheimer's Platform Foundation (GAP) and is chair and co-founder of USAgainstAlzheimer’s (USA2), which convenes CEOi and is a “disruptive,” entrepreneurial and patient-focused US based NGO committed to stopping Alzheimer’s disease by 2020.
Dr Tetsu Maruyama is the Executive Director of the ADDI, where he has the pleasure of working with an exceptional team to enable data relevant to Alzheimer’s and related dementias to reach their full potential.
Harry Johns is the former CEO of the Alzheimer's Association. During his tenure, the Association, working with leading members of the U.S.
Husseini K Manji, MD, FRCPC is Global Head, J&J Science for Minds, and immediate past Therapeutic Head for Neuroscience at Janssen Research & Development, one of the Johnson & Johnson pharmaceutical companies. His research has investigated disease- and treatment-induced changes in gene and protein networks that regulate synaptic and neural plasticity in neuropsychiatric disorders. This has led to the FDA approval of the first novel antidepressant mechanism (NMDA-antagonism) in decades and has been actively involved in developing biomarkers to help refine these diseases.
World Dementia Council (WDC) Chair, Professor Yves Joanette, gave an invited lecture at the twelfth annual meeting of the Italian Society for Dementia in Florence, Italy on Thursday 16th March 2017. In his lecture, “A Global Response to the Global Challenge of Dementia,” Professor Joanette talked about the many diseases that cause dementia; the increase in the global impact of dementia, including in terms of the number of people affected and the spiralling cost of the disease; and the fear that dementia causes in older people.